Barcelona, Spain · Founded 2012 · Privately Held (backing)
Operator of a biotechnology company intended to develop genetic medicines through protein-splicing gene therapy. SpliceBio is based in Barcelona, Spain and was founded in 2012. Its last reported valuation was $84.5 million in Feb 2022. It has raised $198 million.
Last reported valuation
$84.5M
Oct 2026
Priced at
—
Total raised
$198.0M
Last round
—
Team — not yet on record
No current team members for SpliceBio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of SpliceBio with a free account
·The complete investor list: 11 names
·Watch SpliceBio: the Monday email on marks, rounds and moves
